PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2D324F286Z4565951766!doxycycline hydrochloride injection — Fresenius Kabi, LLC

Fresenius Kabi, LLC holds $98.3M across 1,575 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 2 related awards under parent SPE2D020D0009. PoP ended Sep 27, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support
Awarding office
Fresenius Kabi, LLC
Recipient
Sep 27, 2024
PoP end
$110K
Obligated
$110K
Potential
325411
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Fresenius Kabi, LLC — $90

Contract facts

Federal
Contract numberSPE2D324F286Z
Also listed asSPE2D020D0009-SPE2D324F286Z
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentFresenius Kabi, LLC
CAGE57KZ6
UEIC2TRNWNQKMD6
NAICS325411

No full NAICS 325411 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDVSPE2D020D0009
Place of performanceLAKE ZURICH IL
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startSep 24, 2024
PoP end (current)Sep 27, 2024
Obligated$110K
Current value$110K
Potential value$110K

4565951766!DOXYCYCLINE HYDROCHLORIDE INJECTION (10) is a federal award for Dla Troop Support held by Fresenius Kabi, LLC. Estimated value $110K ($110K obligated). Current period of performance ends Sep 27, 2024. Place of performance: LAKE ZURICH IL.

4565951766!DOXYCYCLINE HYDROCHLORIDE INJECTION (10)

Recompete timing

Public
Past PoP end (693 days ago)

Current PoP ended Sep 27, 2024 (693 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Fresenius Kabi, LLC$98.3M obligated across 1,575 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($98.3M) · all agencies
Department of Health and Human Services (HHS)$94.1M · 96%Department of Defense (DOD)$4.2M · 4%
Open full company profile

Related awards

Same parent · incumbent
SPE2D025F0535
8511525788!OTHER MEDICAL
$1.4M
Aug 31, 2026
75A50326F80006
ATROPINE 0.4MGML X 20ML SOLN. FOR INJ., MULTI-DOSE VIALS 8MG AND MIDAZOLAM SOLN. FOR INJ.,…
$7.9M
Jul 29, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2D324F286Z?

SPE2D324F286Z (4565951766!doxycycline hydrochloride injection) is a Dla Troop Support award with a potential value of $110K, currently held by Fresenius Kabi, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2D324F286Z?

Dla Troop Support awarded SPE2D324F286Z to Fresenius Kabi, LLC (potential $110K).

Who is the incumbent on SPE2D324F286Z?

Fresenius Kabi, LLC is the incumbent with $98.3M across 1575 related awards in SCOUT’s public footprint. The current period of performance ends Sep 27, 2024.

When does Fresenius Kabi, LLC’s SPE2D324F286Z come up for recompete?

SCOUT tracks a period-of-performance end of Sep 27, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2D324F286Z